Insulet Estimates Up to 40 Million Dollars in Costs Following Omnipod 5 Pod Recall but Maintains 2026 Growth Guidance
Insulet Corporation, a prominent leader in tubeless insulin pump technology, has disclosed in a recent federal financial filing that it…
